Literature DB >> 28213762

Association between cognitive impairment and urinary dysfunction in Parkinson's disease.

Zuzanna Tkaczynska1,2, Andrea Pilotto2,3, Sara Becker1,2, Susanne Gräber-Sultan1,2, Daniela Berg2,4, Inga Liepelt-Scarfone5,6.   

Abstract

Urinary dysfunction (UD) is a common non-motor feature of Parkinson's disease (PD), and might be secondary to neurodegeneration involving cortical and subcortical brain areas. The possible link between UD and cognitive deficits has never been examined in frontal cortex impairment, and is still not completely understood in PD. In the present study, 94 PD patients underwent a comprehensive motor, cognitive and non-motor assessment. It was shown that 55.3% of patients reported UD, of which 17% needed specific urological treatment. Patients who reported UD performed worse on global cognition (PANDA, p = .05), visuo-constructive functions (CERAD/praxis, p = .03; and Figure Test, p = .03), and instrumental activities of daily living functions (IADL, p = .03), than patients without UD. The group with UD medication performed worse on global cognition (PANDA, p = .02) and visuo-constructive functions (CERAD/praxis, p = .05; CERAD/praxis recall, p = .05) than the UD group without medication, independent of anticholinergic treatment effect. Our findings suggest an association between cognitive impairment and UD in PD independent from symptomatic treatment.

Entities:  

Keywords:  Bladder dysfunction; Cognition; Dementia; Neuropsychology; Parkinson’s disease; Urge incontinence

Mesh:

Substances:

Year:  2017        PMID: 28213762     DOI: 10.1007/s00702-017-1690-2

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  35 in total

Review 1.  Bladder dysfunction in Parkinsonism: mechanisms, prevalence, symptoms, and management.

Authors:  Kristian Winge; Clare J Fowler
Journal:  Mov Disord       Date:  2006-06       Impact factor: 10.338

2.  Dementia associated with Parkinson's disease: applying the Movement Disorder Society Task Force criteria.

Authors:  P Martinez-Martin; C Falup-Pecurariu; C Rodriguez-Blazquez; M Serrano-Dueñas; F J Carod Artal; J M Rojo Abuin; D Aarsland
Journal:  Parkinsonism Relat Disord       Date:  2011-06-30       Impact factor: 4.891

Review 3.  Neural control of the lower urinary tract.

Authors:  William C de Groat; Derek Griffiths; Naoki Yoshimura
Journal:  Compr Physiol       Date:  2015-01       Impact factor: 9.090

4.  Assessment of voiding dysfunction in Parkinson's disease by the international prostate symptom score.

Authors:  I Araki; S Kuno
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-04       Impact factor: 10.154

5.  Lower urinary tract function in dementia with Lewy bodies (DLB).

Authors:  Fuyuki Tateno; Ryuji Sakakibara; Tsuyoshi Ogata; Masahiko Kishi; Yohei Tsuyusaki; Osamu Takahashi; Megumi Sugiyama; Akihiko Tateno
Journal:  Mov Disord       Date:  2014-10-30       Impact factor: 10.338

6.  The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

Authors:  J L Cummings; M Mega; K Gray; S Rosenberg-Thompson; D A Carusi; J Gornbein
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

7.  The anticholinergic risk scale and anticholinergic adverse effects in older persons.

Authors:  James L Rudolph; Marci J Salow; Michael C Angelini; Regina E McGlinchey
Journal:  Arch Intern Med       Date:  2008-03-10

Review 8.  Depression, Anxiety and the Bladder.

Authors:  Ryuji Sakakibara; Takashi Ito; Tatsuya Yamamoto; Tomoyuki Uchiyama; Tomonori Yamanishi; Masahiko Kishi; Yohei Tsuyusaki; Fuyuki Tateno; Shuichi Katsuragawa; Nobuo Kuroki
Journal:  Low Urin Tract Symptoms       Date:  2013-03-31       Impact factor: 1.592

9.  Cognitive profiles in Parkinson's disease and their relation to dementia: a data-driven approach.

Authors:  Inga Liepelt-Scarfone; Susanne Gräber; Monika Fruhmann Berger; Anne Feseker; Gülsüm Baysal; Ilona Csoti; Jana Godau; Alexandra Gaenslen; Heiko Huber; Karin Srulijes; Kathrin Brockmann; Daniela Berg
Journal:  Int J Alzheimers Dis       Date:  2012-10-18

10.  Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease.

Authors:  James A G Crispo; Allison W Willis; Dylan P Thibault; Yannick Fortin; Harlen D Hays; Douglas S McNair; Lise M Bjerre; Dafna E Kohen; Santiago Perez-Lloret; Donald R Mattison; Daniel Krewski
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240

View more
  5 in total

1.  Relationship between Lower Urinary Tract Dysfunction and Clinical Features in Chinese Parkinson's Disease Patients.

Authors:  Duo Xu; Shunchang Han; Jue Wang; Juan Feng
Journal:  Parkinsons Dis       Date:  2019-03-05

2.  Adherence to Pharmacotherapy in Patients With Parkinson's Disease Taking Three and More Daily Doses of Medication.

Authors:  Igor Straka; Michal Minár; Matej Škorvánek; Milan Grofik; Katarína Danterová; Ján Benetin; Egon Kurča; Andrea Gažová; Veronika Boleková; Kathryn A Wyman-Chick; Ján Kyselovič; Peter Valkovič
Journal:  Front Neurol       Date:  2019-07-31       Impact factor: 4.003

3.  Prevalence of lower urinary tract symptoms, urinary incontinence and retention in Parkinson's disease: A systematic review and meta-analysis.

Authors:  Fang-Fei Li; Yu-Sha Cui; Rui Yan; Shuang-Shuang Cao; Tao Feng
Journal:  Front Aging Neurosci       Date:  2022-09-12       Impact factor: 5.702

4.  Executive Function Is Related to the Urinary Urgency in Non-demented Patients With Parkinson's Disease.

Authors:  Zuzanna Tkaczynska; Sara Becker; Walter Maetzler; Maarten Timmers; Luc Van Nueten; Patricia Sulzer; Giacomo Salvadore; Eva Schäffer; Kathrin Brockmann; Johannes Streffer; Daniela Berg; Inga Liepelt-Scarfone
Journal:  Front Aging Neurosci       Date:  2020-03-06       Impact factor: 5.750

5.  Subsequent risk of acute urinary retention and androgen deprivation therapy in patients with prostate cancer: A population-based retrospective cohort study.

Authors:  Teng-Kai Yang; Chia-Chang Wu; Chao-Hsiang Chang; Chih-Hsin Muo; Chao-Yuan Huang; Chi-Jung Chung
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.